There are a variety of non-statin lipid-lowering medications with proven cardiovascular benefits; however, most of the evidence supporting their use has been as an adjunct with a statin. Bempedoic acid offers a novel mechanism of action to treat hypercholesterolemia. But is there a CLEAR role for bempedoic acid in the treatment and prevention of ASCVD in statin-intolerant patients?

Guest Authors: Sarah B. Edwards, PharmD and Briana Williams, PharmD, BCPS, BCACP

Special Guest: Joseph Saseen, PharmD, BCPS, BCACP

Music by Good Talk